
Biosecurity Innovation and Risk Reduction Initiative
Advances in biotechnology outpace national governments’ ability to provide needed oversight to prevent accidents or deliberate misuse of dangerous biological agents.
Biological threats – whether natural, accidental or deliberate — can kill millions, cost billions, and create political and economic instability in individual countries and around the world. The risks and consequences of a global catastrophic biological event can be magnified by weak global health security, increasing urbanization and travel, growing terrorist interest in weapons of mass destruction, and rapid advances in technology that enable newly developed or manipulated pathogens with pandemic potential.
To reduce these risks and strengthen biosecurity, NTI | bio works with governments, industry, academia, international organizations and NGOs to foster multilateral dialogue, identify weaknesses, and promote systemic change to improve biotechnology governance and national health security capacities.
NTI offers solutions through a range of projects. Among them:
Advances in biotechnology outpace national governments’ ability to provide needed oversight to prevent accidents or deliberate misuse of dangerous biological agents.
Reducing biological risk and enhancing global security
Preventing global catastrophic biological risks (GCBRS)
The GHS Index highlights individual country needs, boost compliance with international standards, and create better understanding of global capabilities to prevent, detect, and respond to biological threats.
Safeguarding modern bioscience and biotechnology so it can advance and flourish safely and responsibly
Rapidly assessing origins of high-consequence global biological events
Cultivating the Next Generation of Global Biosecurity Leaders
Establishing an international Common Mechanism for DNA Synthesis Screening
NTI is pleased to announce the appointment of Nathan A. Paxton as a senior director on NTI’s Global Biological Policy and Programs team (NTI | bio).
In a new opinion piece for The Economist, Jaime Yassif makes the case for urgent action to create stronger guardrails for bioscience and biotechnology.
NTI | bio experts contributed to the 9th Biological Weapons Convention Review Conference in Geneva.
NTI | bio partnered with Carnegie India as a "knowledge partner" for the 2022 Global Technology Summit and led two sessions on global biosecurity and biosafety.
As the war in Ukraine continues, destroying cities and causing the worst humanitarian crisis in Europe in a generation, NTI’s policy experts are fanning out across the news media to discuss the implications of Putin’s actions